Antagonism between estradiol and progestin on Bcl-2 expression in breast-cancer cells

International Journal of Cancer

Volumn 68, Issue 1, 1996, Pages 120-125

  Kandouz, Mustapha ^a   Siromachkova, Marcella ^a   Jacob, Denis ^a,c   Marquet, Bertrand Chretien ^b   Therwath, Amu ^a   Gompel, Anne ^a,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

11 [4 [[5 [(4,4,5,5,5 PENTAFLUOROPENTYL)SULFONYL]PENTYL]OXY]PHENYL]ESTRADIOL; 16ALPHA ETHYL 21 HYDROXY 19 NORPREGN 4 ENE 3,20 DIONE; 4 HYDROXYTAMOXIFEN; ESTRADIOL; PROTEIN BCL 2; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; CELL STRAIN MCF 7; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0029903439     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960927)68:1<120::AID-IJC21>3.0.CO;2-E     Document Type: Article

References (32)

1. ABRAHAM, G.E., MAROULIS, G.B. and MARSHALL, J.R., Evaluation of ovulation and corpus luteum function using measurements of plasma progesterone. Obstet. Gynecol., 44, 522-525 (1974).
2. BROOKS, S.C., LOCKE, E.R. and SOULE, H., Estrogen receptor in a human cell line (MCF-7) from breast carcinoma. J. biol. Chem., 248, 6251-6253 (1973).
3. CHLEQ-DESCHAMPS, C-M., LEBRUN, D.P., HUIE, P., BESNIER, D., WARNKE, R.A., SIBLEY, R. and CLEARY, M.L., Topographical dissociation of Bcl-2 messenger RNA and protein expression in human lymphoid tissues. Blood, 81, 293-298 (1993).
4. DUBIK, D., DEMBINSKI, T.C. and SCHU, R.P.C., Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast-cancer cells. Cancer Res., 47, 6517-6521 (1987).
5. ELLIS, R.E., YUAN, J. and HORWITZ, H.R., Mechanisms and function of cell death. Ann. Rev. Cell Biol., 7, 663-698 (1991).
6. FERGUSON, D.J.P. and ANDERSON, T.J., Morphological evaluation of cell turnover in relation to the menstrual cycle in the "resting" human breast. Brit. J. Cancer, 44, 177-181 (1981).
7. GARCIA, I., MARTINOU, I., TSUJIMOTO, Y. and MARTINOU, J-C., Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. Science, 258, 302-304 (1992).
8. GOING, J.J., ANDERSON, T.J., BATTERSBY, S. and MACINTYRE, C.C.A., Proliferative and secretory activity in human breast during natural and artificial menstrual cycles. Amer. J. Pathol., 13, 193-204 (1988).
9. GOMPEL, A., MALET, C., SPRITZER, P., LALARDRIE, J.P., KUTTENN, F. and MAUVAIS-JARVIS, P., Progestin effect on proliferation and 17 β hydroxysteroid-dehydrogenase activity in normal breast cells in culture. J. clin. Endocrinol. Metab., 63, 1174-1180 (1986).
10. GOMPEL, A., SABOURIN, J.C., MARTIN, A., YANEVA, H., AUDOIN, J., DECROIX, Y. and POITOUT, P., Bcl-2 expression in normal endometrium during the menstrual cycle. Amer. J. Pathol., 144, 1135-1202 (1994).
11. HALDAR, S., NEGRINI, M., MONNE, M., SABBIONI, S. and CROCE, C.M., Down-regulation of Bcl-2 by p53 in breast-cancer cells. Cancer Res., 54, 2095-2097 (1994).
12. HOCKENBERY, D.M., NUNCY, G., MILLIMAN, C., SCHREIBER, R.D. and KORSMEYER, S.J., Bcl-2 is a inner mitochondrial membrane protein that blocks programmed cell death. Nature (Lond.), 348, 334-336 (1990).
13. HORWITZ, K.B., MOCKERS, M.B. and LESSEY, B.A., Variant T47-D human breast-cancer cells with high progesterone-receptor levels despite estrogen and anti-estrogen resistance. Cell, 28, 633-642 (1982).
14. KERR, J.F.K., WYLLIE, A.H. and CURRIE, A.H., Apoptosis, a basic biological phenomenon with wider implications in tissue kinetics. Brit. J. Cancer, 26, 239-245 (1972).
15. KYPRIANOU, M., ENGLISH, H.F., DAVIDSON, N.E. and ISAACS, J.T., Programmed cell death during regression of the MCF-7 human breast-cancer cells following estrogen ablation. Cancer Res., 51, 162-166 (1991).
16. LEEK, R.D., KATLANMANIS, L., PEZZELLA, F., GATTER, K.C. and HARRIS, A.L., Bcl-2 in normal human breast and carcinoma, association with oestrogen-receptor-positive, epidermal-growth-factor-receptor-negative tumours and in situ cancer. Brit. J. Cancer, 69, 135-139 (1994).
17. LEYGUE, E., GOL WINKLER, R., GOMPEL, A., LOUIS SYLVESTRE, C., SOQUET, L., STAUB, S., KUTTENN, F. and MAUVAIS JARVIS, P., Estradiol stimulates c-myc proto-oncogene expression in normal human breast epithelial cells in culture. J. Steroid Biochem. mol. Biol., 52, 299-305 (1995).
18. LIPPMAN, M.E., DICKSON, R.B., BATES, S., KNABBE, C., HUFF, K., SWAIN, S., MCMANAWAY, M., BRONZERT, D., KASID, A. and GELMANN, E.P., Autocrine and paracrine growth regulation of human breast cancer. Breast Cancer Res. Treat., 7, 59-70 (1986).
19. LU, P.J., LU, Q.L., RUGHETTI, A. and TAYLOR-PAPADIMITRIOU, J.T., Bcl-2 over-expression inhibits cell death and promotes the morphogenesis, but not tumorigenesis of human mammary epithelial cells. J. Cell Biol., 129, 1363-1378 (1995).
20. LU, Q.L., HANBY, A.M., NASSER HAJIBAGHERI, M.A., GSCHMEISSNER, S.E., LU, P.J., TAYLOR-PAPADIMITRIOU, J., KRAJEWSKI, S., REED, J.C. and WRIGHT, N.A., Bcl-2 protein localizes to the chromosomes of mitotic nuclei and is correlated with the cell cycle in cultured epithelial cell lines. J. Cell Sci., 107, 363-371 (1994).
21. NARDULLI, A.M., GREENE, G.G., O'MALLEY, B.W. and KATZENELLEN-BOGEN, B.S., Regulation of progesterone-receptor-messenger ribonucleic acid and protein levels in MCF-7 cells by estradiol: analysis of estrogen effect on progesterone-receptor synthesis and degradation. Endocrinology, 122, 935-944 (1988).
22. OLTVAI, Z.N., MILLIMAN, C.L. and KORSMEYER, S.J., Bcl-2 het-erodimerizes with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 74, 709-619 (1993).
23. REED, J.C., TSUJIMOTO, Y., ALPERS, J.D., CROCE, C.M. and NOWELL, P.C., Regulation of bcl-2 proto-oncogene expression during normal human lymphocyte proliferation. Science, 236, 1295-1297 (1987).
24. SABOURIN, J.C., MARTIN, A., BARUCH, J., TRUC, J.B., GOMPEL, A. and POITOUT, P.M., Bcl-2 expression in normal breast tissue during the menstrual cycle. Int. J. Cancer., 59, 1-6 (1994).
25. SAMBROOK, J., FRITSCH, E.F. and MANIATIS, T., Molecular cloning (3rd ed.), Cold Spring Harbor Laboratory, New York (1989).
26. SATO, T., HANADA, M., BODRUG, S., IRIE, S., IWAMA, N., BOISE, L., THOMPSON, C., FONG, L., GOLEMIS, E., WANG, H.-G. and REED, J.C., Investigations of Bcl-2-protein-family interactions using yeast two-hybrid system. Proc. not. Acad. Sci. (Wash.), 91, 9238-9242 (1994).
27. SETO, M., JAEGER, U., HOCKETT, R.D., GRANINGER, W., BENNETT, S., GOLDMAN, P. and KORSMEYER, S.J., Alternative promoters and exons, somatic mutation and de-regulation of the bcl-2-Ig fusion gene in lymphoma. EMBO J., 7, 123-131 (1988).
28. TEIXEIRA, C., REED, J.C. and PRATT, C., Estrogen promotes chemotherapeutic drug resistance by a mechanism involving bcl-2 proto-oncogene expression in human breast-cancer cells. Cancer Res., 55, 3902-3907 (1995).
29. TSUJIMOTO, Y. and CROCE, C.M., Analysis of the structure, transcripts and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. nat. Acad. Sci. (Wash.), 83, 5214-5218 (1986).
30. VAUX, D.L., CORY, S. and ADAMS, J.M., bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature (Lond.), 335, 440-442 (1988).
31. WANG, T.T.Y. and PHANG, J.M., Effects of estrogen on apoptotic pathways in human breast-cancer cell line MCF-7. Cancer Res., 55, 2487-2489 (1995).
32. WILING, G., LIPPMAN, M.E. and GELMAN, E.P., Effects of steroid hormones and peptide growth factors on proto-oncogene c-fos expression in human breast-cancer cells. Cancer Res., 48, 802-805 (1988).